Changes of plasma asymmetric dimethylarginine levels in the first six months after renal transplant
Changes of plasma asymmetric dimethylarginine levels in the first six months after renal transplant
To assess the changes of plasma asymmetric dimethylarginine (ADMA) levels and its potential associations with patient characteristics after six months of renal transplant. Subjects and methods: A prospective, descriptive study which enrolled 83 recipients at 6 months after renal transplant compared to 83 healthy people at Military Hospital 103 from March 2018 to April 2020.